Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Shaughnessy

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Hematology|May 7, 2003
Global gene expression profiling in the study of multiple myelomaJohn D Shaughnessy
Clinical Advances in Hematology & Oncology : H&O|September 20, 2006
Clinical use of genomics in multiple myelomaJohn D Shaughnessy
Nature|July 11, 2008
Cancer: An unexpected addictionJohn D Shaughnessy
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Using genomics to identify high-risk myeloma after autologous stem cell transplantationJohn D Shaughnessy, Bart Barlogie
International Journal of Hematology|November 15, 2002
Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISHBart Barlogie, John D Shaughnessy
International Journal of Hematology|November 15, 2002
Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myelomaJohn D Shaughnessy, Bart Barlogie
Immunological Reviews|July 9, 2003
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profilingJohn D Shaughnessy, Bart Barlogie
Journal of Cellular Biochemistry|January 28, 2006
Role of osteoblast suppression in multiple myelomaJames Peter Stewart, John D Shaughnessy
Seminars in Hematology|June 26, 2012
Proteasome inhibitors: introductionChristoph J Heuck, John D Shaughnessy
The New England Journal of Medicine|July 11, 2008
Duration of survival in patients with myeloma treated with thalidomideBart Barlogie, John D Shaughnessy, John Crowley
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Hematology|May 7, 2003
Global gene expression profiling in the study of multiple myelomaJohn D Shaughnessy
Clinical Advances in Hematology & Oncology : H&O|September 20, 2006
Clinical use of genomics in multiple myelomaJohn D Shaughnessy
Nature|July 11, 2008
Cancer: An unexpected addictionJohn D Shaughnessy
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Using genomics to identify high-risk myeloma after autologous stem cell transplantationJohn D Shaughnessy, Bart Barlogie
International Journal of Hematology|November 15, 2002
Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISHBart Barlogie, John D Shaughnessy
International Journal of Hematology|November 15, 2002
Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myelomaJohn D Shaughnessy, Bart Barlogie
Immunological Reviews|July 9, 2003
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profilingJohn D Shaughnessy, Bart Barlogie
Journal of Cellular Biochemistry|January 28, 2006
Role of osteoblast suppression in multiple myelomaJames Peter Stewart, John D Shaughnessy
Seminars in Hematology|June 26, 2012
Proteasome inhibitors: introductionChristoph J Heuck, John D Shaughnessy
The New England Journal of Medicine|July 11, 2008
Duration of survival in patients with myeloma treated with thalidomideBart Barlogie, John D Shaughnessy, John Crowley
Pageof 15